Strong for helmet protection; insufficient for riding itself
Systematic review & meta-analysis
Helmet use mortality OR ~0.48 in recent meta-analysis; other cohorts ~0.65
Meta-analysis
~9% lower mortality per 1,000 additional steps/day in 2024 meta-analysis; nonlinear benefit
Cohort study
Large cohort: ~6% lower mortality per 1-point increase in overall life satisfaction score (HR ~0.94)
Cohort study
Swedish cohort: each additional decade of parental survival associated with ~22% lower offspring mortality
Limited — ecological/country-level statistic, not an individual mortality study
Ecological / population-level data
National life expectancy at birth varies by roughly a decade across upper-middle vs high-income countries (WHO 2023 estimates); healthcare access and quality are the primary drivers of that gap
Systematic review & meta-analysis
Low skeletal muscle mass index associated with 57% higher all-cause mortality risk (pooled RR 1.57, 95% CI 1.25–1.96) across 16 prospective studies, 81,358 participants
Observational study
Prior cancer diagnosis associated with 29% higher multivariate-adjusted all-cause mortality (HR 1.29, 95% CI 1.22–1.35)
Systematic review & meta-analysis
90-cohort meta-analysis: isolation pooled effect ~1.32; loneliness ~1.14 for all-cause mortality
Meta-analysis
LDL-C ≥160 mg/dL associated with higher all-cause mortality (RR 1.34, 95% CI 1.00–1.80) and CVD death (RR 1.79, 95% CI 1.26–2.54) vs LDL-C 70–129 mg/dL, in a meta-analysis of 1,232,694 adults
Systematic review & meta-analysis
Any resistance training vs none associated with 15% lower all-cause mortality (RR 0.85, 95% CI 0.77–0.93); dose-response peaked at ~60 min/week (27% reduction)
Strong prognostic evidence; generic single HR heterogeneous
Cohort study
Mortality varies substantially by MI/CHD, stroke, HF, PAD and multimorbidity; no single generic CVD HR recommended
Cohort study
UK Biobank: T2D HR 1.59 in White Europeans and 2.83 in South Asians vs no T2D, after broad lifestyle/sociodemographic adjustment